Skip to main content

DHR

Stock

DHR

Stock
Health Care
Diagnostics & Research

Performance overview

DHR Price
Price Chart

Forward-looking statistics

Beta
0.69
Risk
25.16%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Danaher Corporation is an American globally diversified conglomerate founded by brothers Stephen and Mitchell Rales in 1984. Headquartered in Washington, D.C., the company designs, manufactures, and markets medical, industrial, and commercial products and services.

Company info

SectorHealth Care
IndustryDiagnostics & Research
Employees71K
Market cap$194.9B

Fundamentals

Enterprise value$157.0B
Revenue$23.8B
Revenue per employee
Profit margin15.81%
Debt to equity34.56

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$5.16
Dividend per share$1.28
Revenue per share$32.86
Avg trading volume (30 day)$776M
Avg trading volume (10 day)$867M
Put-call ratio

Macro factor sensitivity

Growth+1.0
Credit+2.9
Liquidity-0.6
Inflation-1.4
Commodities+0.7
Interest Rates-1.3

Valuation

Dividend yield0.63%
PEG Ratio24.25
Price to sales6.11
P/E Ratio24.25
Enterprise Value to Revenue6.59
Price to book2.86

Upcoming events

Next earnings dayApril 22, 2025
Next dividend day
Ex. dividend dayJune 27, 2025

News

CVS vs. DHR: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical Services sector have probably already heard of CVS Health (CVS) and Danaher (DHR). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research (June 27, 2025)
Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

Michael Yee, Jefferies senior biotech analyst, joins CNBC's 'Squawk on the Street' to discuss how AI could fuel drug discovery and development, the timeline for when pharmaceutical companies could see benefits from AI, and more.

CNBC Television (May 28, 2025)
Danaher Beats Q1 Expectations, Signals Caution Ahead In 'Unusual Times'

Danaher Corp DHR on Tuesday reported first-quarter 2025 sales of $5.74 billion, down 1% year-over-year, beating the consensus of $5.59 billion.

Benzinga (April 22, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free